GBLX Financial Statements From 2010 to 2024
| GBLX Stock | USD 0.01 0 36.00% |
Check GB Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GBLX main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . GBLX financial statements analysis is a perfect complement when working with GB Sciences Valuation or Volatility modules.
GBLX |
GB Sciences Company Current Valuation Analysis
GB Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current GB Sciences Current Valuation | 10.19 M |
Most of GB Sciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GB Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, GB Sciences has a Current Valuation of 10.19 M. This is 99.93% lower than that of the Healthcare sector and 99.78% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
GB Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GB Sciences's current stock value. Our valuation model uses many indicators to compare GB Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GB Sciences competition to find correlations between indicators driving GB Sciences's intrinsic value. More Info.GB Sciences is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value GB Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GB Sciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GB Sciences' earnings, one of the primary drivers of an investment's value.About GB Sciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include GB Sciences income statement, its balance sheet, and the statement of cash flows. GB Sciences investors use historical funamental indicators, such as GB Sciences's revenue or net income, to determine how well the company is positioned to perform in the future. Although GB Sciences investors may use each financial statement separately, they are all related. The changes in GB Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GB Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on GB Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in GB Sciences. Please read more on our technical analysis and fundamental analysis pages.
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada. Growblox Sciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of GB Sciences Correlation against competitors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for GBLX Pink Sheet analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |